Among the putative human Six1 targets are also the metallophosphoesterase MPPED2, which has been associated with chronic kidney disease (Pattaro et al., 2012; Zhong et al., 2023), and the serine/threonine kinase 39 (STK39), also called SPAK. This evidence concerns the gene STK39 and chronic kidney disease.